anticancer drug library

A unique collection of 3660 drugs with anti-cancer activity or potential anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

The unparalleled chemical diversity of natural products makes them an ideal choice for screening active small molecules. Natural products is always a significant source in drug discovery. According to authoritative statistics, 79 out of 99 small molecule anticancer drugs have been successfully developed based on natural products since 1981. Natural products have demonstrated successful modulation of isolated but crucial targets, especially in antimicrobial targets and protein interactions. Many researchers consider natural products and their derivatives as unique tools for studying and manipulating protein function. The Drug-like Natural Compound Library comprises 522 novel molecules, serving as a complement to the L6000 Natural Product Library. This library enhances the probability of successful drug screening, making it an excellent tool for lead compound discovery.

A unique collection of 507 protease and proteasome inhibitors for research in chemical genomics, and drug screening;

A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;

A unique collection of 1920 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

97 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

A unique collection of 4270 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2684 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);

A unique collection of 23618 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;